SC
Stephen P. Carey (SVP & CFO) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $552K of ANIP (7,312 sh across 2 lots, as filed), executed Mar 5. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.2M
shares × price, as filed
Last traded
Oct 29
Filed Oct 30
Median ADV $26.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
8 filings
Sector per market data · by filing · past 12 months
Most traded names
ANIPRecent filings
ANIPSALE
ANI Pharmaceuticals, Inc.
View filing →
$4.3M50,000 sh × $86.07
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $418K
7,500 sh × $55.79
Exec Dec 17 2024
Filed Dec 18 2024 · 5:30 PM ET